摘要
肺纤维化是一种进行性加重、病死率高的难治性慢性呼吸系统疾病,目前尚无有效的治疗方法。多项研究表明,中药治疗肺纤维化具有独特的优势,本文从气虚、血瘀、痰凝三个方面论述单味中药及其提取物在肺纤维化中的研究进展,以期为肺纤维化治疗提供新的思路及理论依据。
Pulmonary fibrosis is a chronic respiratory disease with progressive aggravation and high mortality.There is no effective treatment at present.A number of studies have shown that TCM has unique advantages in the treatment of pulmonary fibrosis.This study discussed the research progress of single traditional Chinese medicinal and its extracts in treating pulmonary fibrosis in terms of qi deficiency,blood stasis and phlegm coagulation these three aspects,in order to provide new ideas and theoretical basis for the treatment of pulmonary fibrosis.
作者
葛春蕾
张兴彩
李珂珂
GE Chunlei;ZHANG Xingcai;LI Keke(Shandong University of Traditional Chinese Medicine,Jinan 250014,China;The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250014,China)
出处
《中医药学报》
CAS
2020年第6期67-72,共6页
Acta Chinese Medicine and Pharmacology
基金
国家自然科学基金应急管理项目(81641190)
山东省医药卫生科技发展计划项目(2015WS0139)
泰山学者岗位专项基金资助(ts201712096)。
关键词
肺纤维化
中药
研究进展
氧化应激
TGF-Β1
Pulmonary fibrosis
Chinese medicinal
Research progress
Oxidative stress
TGF-β1
